Salim Syed
Stock Analyst at Mizuho Securities
(3.36)
# 2,455
Out of 4,673 analysts
1115
Total ratings
45%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Salim Syed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintained: Hold | $303 → $352 | $439.33 | -19.88% | 172 | Aug 17, 2026 | |
| IOVA Iovance Biotherapeutics | Maintained: Buy | $10 → $11 | $8.29 | +32.69% | 6 | Aug 17, 2026 | |
| ELVN Enliven Therapeutics | Maintained: Buy | $62 → $73 | $59.82 | +22.03% | 18 | Aug 17, 2026 | |
| NKTX Nkarta | Maintained: Buy | $12 | $2.66 | +351.13% | 43 | Aug 17, 2026 | |
| IPSC Century Therapeutics | Maintained: Buy | $8 | $2.07 | +286.47% | 4 | Aug 17, 2026 | |
| RCUS Arcus Biosciences | Maintained: Buy | $47 | $30.34 | +54.91% | 6 | Aug 5, 2026 | |
| BIIB Biogen | Maintained: Buy | $221 → $241 | $216.78 | +11.17% | 133 | Aug 3, 2026 | |
| INCY Incyte | Maintained: Buy | $121 → $137 | $127.81 | +7.19% | 8 | Aug 3, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $27 → $23 | $5.29 | +334.78% | 81 | Aug 3, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $100 → $118 | $76.84 | +53.57% | 146 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $11.89 | +110.26% | 9 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $97 | $29.43 | +229.60% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $96 | $81.50 | +17.79% | 107 | Jun 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $9.70 | +85.57% | 81 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $163 | $62.62 | +160.30% | 24 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $170 | $146.12 | +16.34% | 111 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $45 | $34.38 | +30.89% | 40 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.41 | +314.94% | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $43 | $19.65 | +118.83% | 8 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $2.33 | +243.35% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 | $59.50 | n/a | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $152.55 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.80 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $28.07 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $4.03 | n/a | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.42 | n/a | 73 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $10.30 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $66.70 | n/a | 1 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 | $23.71 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.1 | $9.27 | n/a | 1 | Jul 2, 2019 |
Amgen
Aug 17, 2026
Maintained: Hold
Price Target: $303 → $352
Current: $439.33
Upside: -19.88%
Iovance Biotherapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $10 → $11
Current: $8.29
Upside: +32.69%
Enliven Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $62 → $73
Current: $59.82
Upside: +22.03%
Nkarta
Aug 17, 2026
Maintained: Buy
Price Target: $12
Current: $2.66
Upside: +351.13%
Century Therapeutics
Aug 17, 2026
Maintained: Buy
Price Target: $8
Current: $2.07
Upside: +286.47%
Arcus Biosciences
Aug 5, 2026
Maintained: Buy
Price Target: $47
Current: $30.34
Upside: +54.91%
Biogen
Aug 3, 2026
Maintained: Buy
Price Target: $221 → $241
Current: $216.78
Upside: +11.17%
Incyte
Aug 3, 2026
Maintained: Buy
Price Target: $121 → $137
Current: $127.81
Upside: +7.19%
Wave Life Sciences
Aug 3, 2026
Maintained: Buy
Price Target: $27 → $23
Current: $5.29
Upside: +334.78%
Cytokinetics
Jun 23, 2026
Maintained: Buy
Price Target: $100 → $118
Current: $76.84
Upside: +53.57%
Jun 23, 2026
Maintained: Buy
Price Target: $25
Current: $11.89
Upside: +110.26%
Jun 23, 2026
Maintained: Buy
Price Target: $97
Current: $29.43
Upside: +229.60%
Jun 21, 2026
Maintained: Buy
Price Target: $96
Current: $81.50
Upside: +17.79%
Jun 18, 2026
Maintained: Buy
Price Target: $18
Current: $9.70
Upside: +85.57%
Jun 18, 2026
Maintained: Buy
Price Target: $163
Current: $62.62
Upside: +160.30%
Jun 12, 2026
Maintained: Buy
Price Target: $170
Current: $146.12
Upside: +16.34%
Jun 12, 2026
Maintained: Buy
Price Target: $40 → $45
Current: $34.38
Upside: +30.89%
Jun 10, 2026
Maintained: Buy
Price Target: $10
Current: $2.41
Upside: +314.94%
Mar 30, 2026
Maintained: Buy
Price Target: $45 → $43
Current: $19.65
Upside: +118.83%
Nov 14, 2025
Maintained: Buy
Price Target: $8
Current: $2.33
Upside: +243.35%
May 20, 2025
Maintained: Buy
Price Target: $85
Current: $59.50
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $152.55
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $27.80
Upside: n/a
May 28, 2024
Maintained: Buy
Price Target: $53
Current: $28.07
Upside: n/a
Mar 25, 2024
Maintained: Buy
Price Target: $25
Current: $4.03
Upside: n/a
Jun 16, 2023
Rated: Hold
Price Target: n/a
Current: $1.42
Upside: n/a
Mar 6, 2023
Maintained: Buy
Price Target: $21
Current: $10.30
Upside: n/a
Nov 3, 2022
Maintained: Buy
Price Target: $23
Current: $66.70
Upside: n/a
Aug 4, 2022
Maintained: Buy
Price Target: $25
Current: $23.71
Upside: n/a
Jul 2, 2019
Maintained: Buy
Price Target: $7.1
Current: $9.27
Upside: n/a